Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat vs Reference Products in Plaque Psoriasis
NCT03399526Phase 1Completed
- Sponsor
- Bayer
- Start
- Feb 2013
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of mapracorat in plaque psoriasis (5 arms), sponsored by Bayer. Primary endpoint: Psoriatic Infiltrate Thickness. Started Feb 2013; status: completed.
02
Drugs
mapracorat
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03399526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399526.